Flagship Harbor Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $467K | Buy |
+890
| New | +$467K | 0.02% | 491 |
|
|
2024
Q4 | – | Sell |
-244
| Closed | -$257K | – | 773 |
|
|
2024
Q3 | $257K | Buy |
+244
| New | +$257K | 0.01% | 610 |
|
|
2024
Q1 | $249K | Buy |
259
+19
| +8% | +$18.3K | 0.02% | 578 |
|
|
2023
Q4 | $211K | Buy |
+240
| New | +$211K | 0.02% | 584 |
|
|
2023
Q2 | – | Sell |
-957
| Closed | -$786K | – | 648 |
|
|
2023
Q1 | $786K | Buy |
957
+189
| +25% | +$155K | 0.07% | 258 |
|
|
2022
Q4 | $554K | Buy |
768
+442
| +136% | +$319K | 0.06% | 308 |
|
|
2022
Q3 | $225K | Buy |
+326
| New | +$225K | 0.03% | 518 |
|
|
2020
Q4 | – | Sell |
-222
| Closed | -$124K | – | 1455 |
|
|
2020
Q3 | $124K | Sell |
222
-57
| -20% | -$31.8K | 0.02% | 590 |
|
|
2020
Q2 | $173K | Buy |
279
+110
| +65% | +$68.2K | 0.03% | 489 |
|
|
2020
Q1 | $83K | Sell |
169
-156
| -48% | -$76.6K | 0.02% | 610 |
|
|
2019
Q4 | $122K | Hold |
325
| – | – | 0.02% | 561 |
|
|
2019
Q3 | $90K | Sell |
325
-47
| -13% | -$13K | 0.02% | 613 |
|
|
2019
Q2 | $116K | Buy |
372
+9
| +2% | +$2.81K | 0.02% | 536 |
|
|
2019
Q1 | $149K | Sell |
363
-29
| -7% | -$11.9K | 0.03% | 478 |
|
|
2018
Q4 | $146K | Sell |
392
-36
| -8% | -$13.4K | 0.04% | 436 |
|
|
2018
Q3 | $169K | Sell |
428
-34
| -7% | -$13.4K | 0.03% | 458 |
|
|
2018
Q2 | $159K | Buy |
+462
| New | +$159K | 0.03% | 459 |
|